These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 7990448)

  • 61. Drug testing in the workplace.
    Phan HM; Yoshizuka K; Murry DJ; Perry PJ
    Pharmacotherapy; 2012 Jul; 32(7):649-56. PubMed ID: 22605533
    [TBL] [Abstract][Full Text] [Related]  

  • 62. A method for the confirmation and identification of drugs of misuse in urine using solid phase extraction and gas-liquid chromatography with mass spectrometry.
    Galloway JH; Ashford M; Marsh ID; Holden M; Forrest AR
    J Clin Pathol; 1998 Apr; 51(4):326-9. PubMed ID: 9659249
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Analysis of drugs of abuse in urine by gas chromatography/mass spectrometry: experience and application.
    Karacić V; Skender L
    Arh Hig Rada Toksikol; 2000 Dec; 51(4):389-400. PubMed ID: 11276966
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Method comparison of EMIT 700 and EMIT II with RIA for drug screening.
    Armbruster DA; Schwarzhoff RH; Pierce BL; Hubster EC
    J Anal Toxicol; 1994; 18(2):110-7. PubMed ID: 8207931
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Screening of amphetamine/methamphetamine and their derivatives in urine using FPIA and Triage 8 and the Scope and limits of a subsequent identification by means of the REMEDi HS system.
    Felscher D; Schulz K
    J Forensic Sci; 2000 Nov; 45(6):1327-31. PubMed ID: 11110193
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Drug screening and confirmation by GC-MS: comparison of EMIT II and Online KIMS against 10 drugs between US and England laboratories.
    Lu NT; Taylor BG
    Forensic Sci Int; 2006 Mar; 157(2-3):106-16. PubMed ID: 15899564
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Assessment of the EMIT-(TM) technique as a screening test for opiates and methadone for a methadone maintenance clinic and its calibration by Bayesian statistics.
    Cavanagh K; Draisey TF; Thibert RJ
    Clin Biochem; 1978 Oct; 11(5):210-3. PubMed ID: 365392
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Rapid screening of drugs of abuse and their metabolites by gas chromatography/mass spectrometry: application to urinalysis.
    Strano-Rossi S; Molaioni F; Rossi F; Botrè F
    Rapid Commun Mass Spectrom; 2005; 19(11):1529-35. PubMed ID: 15880665
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Workplace drug testing in Italy - critical considerations.
    Vignali C; Stramesi C; Morini L; Pozzi F; Collo G; Groppi A
    Drug Test Anal; 2013 Apr; 5(4):208-12. PubMed ID: 23355251
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Alcohol and drugs use among drivers injured in road accidents in Campania (Italy): A 8-years retrospective analysis.
    Carfora A; Campobasso CP; Cassandro P; Petrella R; Borriello R
    Forensic Sci Int; 2018 Jul; 288():291-296. PubMed ID: 29793195
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Comparison between drug screening by immunoassay and ultra-high performance liquid chromatography/high-resolution time-of-flight mass spectrometry in post-mortem urine.
    Sundström M; Pelander A; Ojanperä I
    Drug Test Anal; 2015 May; 7(5):420-7. PubMed ID: 24953563
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Mechanism of interferences for gas chromatography/mass spectrometry analysis of urine for drugs of abuse.
    Wu AH
    Ann Clin Lab Sci; 1995; 25(4):319-29. PubMed ID: 7668815
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Modification and evaluation of Abuscreen OnLine assays for drug metabolites in urine performed on a COBAS FARA II in comparison with EMIT d.a.u. Cannabinoid 20.
    Hailer M; Glienke Y; Schwab IM; von Meyer L
    J Anal Toxicol; 1995; 19(2):99-103. PubMed ID: 7769796
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Flunitrazepam excretion patterns using the Abuscreen OnTrak and OnLine immunoassays: comparison with GC-MS.
    Salamone SJ; Honasoge S; Brenner C; McNally AJ; Passarelli J; Goc-Szkutnicka K; Brenneisen R; elSohly MA; Feng S
    J Anal Toxicol; 1997 Sep; 21(5):341-5. PubMed ID: 9288585
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Application of the multiple drugs immunoassay test for rapid detection of drug abuse in postmortem urine.
    Srisont S; Chirachariyavej T; Peonim AV
    J Med Assoc Thai; 2010 Nov; 93(11):1301-9. PubMed ID: 21114210
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Simultaneous detection of seven drugs of abuse by the Triage panel for drugs of abuse.
    Buechler KF; Moi S; Noar B; McGrath D; Villela J; Clancy M; Shenhav A; Colleymore A; Valkirs G; Lee T
    Clin Chem; 1992 Sep; 38(9):1678-84. PubMed ID: 1525997
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Suspected pediatric ingestions: effectiveness of immunoassay screens vs. gas chromatography/mass spectroscopy in the detection of drugs and chemicals.
    Kyle PB; Spencer JL; Purser CM; Eddleman KC; Hume AS
    J Toxicol Clin Toxicol; 2003; 41(7):919-25. PubMed ID: 14705835
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Determination of benzodiazepines in clinical serum samples: comparative evaluation of REMEDi system, aca analyzer, and conventional HPLC performance.
    Chang TL; Chen KW; Lee YD; Fan K
    J Clin Lab Anal; 1999; 13(3):106-11. PubMed ID: 10323474
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Survey on drugs-of-abuse testing in the European Union.
    Badia R; Segura J; Artola A; de la Torre R
    J Anal Toxicol; 1998; 22(2):117-26. PubMed ID: 9547408
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Evaluation of the DrugCheck 9 on-site immunoassay test cup according to a standard method validation protocol.
    Taylor EH; Pizzo P
    J Anal Toxicol; 2004 Apr; 28(3):190-7. PubMed ID: 15107150
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.